Abstract

International Journal of Pharmacology and Clinical Sciences,2022,11,3,65-71.DOI:10.5530/ijpcs.2022.11.13Published:December 2022Type:Research Article Authors:Yousef Ahmed Alomi, Nouf Saad Al-Saban, Maha Hussein Almadany, Randa Jaroudi, Faisal Safouq Alanazi, and Musleh Samil Reshidi Author(s) affiliations:Yousef Ahmed Alomi*, BSc. Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE, Critical care clinical pharmacists TPN clinical pharmacist Freelancer Business Planner, Content Editor, and Data Analyst,Riyadh, SAUDI ARABIA. Nouf Saad Al-Saban, Bsc. Pharm Patient Safety Specialist Saudi Patient Safety Center Riyadh, SAUDI ARABIA. Maha Hussein Almadany, Bsc. Pharm, Health Care Quality Management Professional Diploma (HCQM), Pharmacy Quality department, King Salman bin Abdulaziz Medical City, Al Madina Al Monwarah, SAUDI ARABIA. Randa Jaroudi, BSc, PharmD TPN Clinical Pharmacist, Freelance TPN Consultation, SAUDI ARABIA. Faisal Safouq Alanazi, BSc. Pharm, Pharm.D, MSc. Clin Pharm, Pharmaceutical Care Services, MOH, Hafar Albatin, SAUDI ARABIA. Musleh Samil Reshidi, BSc. Pharm, MSc. Clinic Pharm, Allied Medical Services Hail, SAUDI ARABIA. Abstract:Objectives: To explore pharmacist’s knowledge of High-risk/Alert medications in Saudi Arabia. Methods: It analyzes a cross-sectional survey discussing pharmacist knowledge of High-risk/Alert medications in Saudi Arabia. The survey consisted of respondents’ demographic information about pharmacists, the High-risk/Alert medications assessment of basic knowledge, and The Resources used about the High risk or high-alert medications. The 5-point Likert response scale system was used with closed-ended questions. The survey was validated through the revision of expert reviewers and pilot testing. Besides, various tests of the reliability of McDonald’s ω, Cronbach alpha, Gutmann’s λ2, and Gutmann’s λ6 been done with the study. Furthermore, the data analysis of the pharmacist’s knowledge of High-risk/ Alert medications is done through the survey monkey system. Besides, the statistical package of social sciences (SPSS), Jeffery’s Amazing Statistics Program (JASP), and Microsoft Excel sheet version 16. Results: A total number of 442 pharmacists responded to the questionnaire. Of them, more than one-third responded from the Central region (183 (40.40%)), and one Quarter responded from the Western part (119 (26.92%)), with statistically significant differences between the provinces (p=0.000). Males responded more than females (264 (59.59%)) versus 179 (40.41%)), with statistically significant differences between all levels (p=0.000). Most of the responders were in the age group of 24-30 years (266 (59.91%)) and 31-35 years (78 (17.57%)), with statistically significant differences between all age groups (p=0.000). Most of the pharmacists were staff pharmacists (323 (72.75%)) and pharmacy supervisors (56 (12.61%)), with statistically significant differences between all levels (p=0.000). The average score of knowledge of pharmacists about High-risk/ Alert medications was (3.71). The pharmacists familiar with prohibited abbreviations during High-risk/Alert prescribing medications obtained the highest score (4.42). The element “heard about the concept of High-risk/Alert medications” got the second highest score (4.39), with a statistically significant difference between the responses (p<0.000). Followed by the pharmacists familiar with look-alike sound-alike of Highrisk/ Alert medications (4.30) and know the narcotics and controlled medications (4.27) ), with a statistically significant difference between the responses (p<0.000). The most used resources for High-risk/Alert or high-alert medication information were Drug information resources (Lexi comp-drug information, Micromedex, Epocrates etc. 345 (78.05%), and Scientific literature 222 (50.23%). They were followed by Health practitioners 206 (46.61%) SFDA website 157 (35.52%). Conclusion: The pharmacist’s knowledge of High-risk/Alert medications is adequate in Saudi Arabia. However, an expanded basic and advanced understanding of High-risk/Alert areas is needed to improve pharmacy performance, patient safety, and quality of life in Saudi Arabia. Keywords:Alert, Drugs., High-risk, Knowledge, Medications, PharmacistView:PDF (275.13 KB) PDFClick here to download the PDF file. Images Pharmacist’s Knowledge of High-risk/Alert Medications in Saudi Arabia

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.